EMA (EU)
GUIDANCE FINAL
Concept paper on the revision of the guideline on pharmaceutical fixed combination products (EMA/CVMP/83804/2005-Rev.1)
Published: 7/24/2026Detected: 7/24/2026
Summary preview
Clarifies and expands the EMA/CVMP guidance for evaluating pharmaceutical fixed combination veterinary medicinal products, aiming to improve consistency of efficacy, safety, and residues documentation expectations under…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
pediatrics
respiratory
manufacturing
quality
clinical
safety
labeling
#veterinary medicinal products
#fixed combination products
#pharmaceutical fixed combinations
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 202611/23/2026
- Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines11/20/2026
- EMA annual call with General Practitioner Organisations' representatives11/20/2026
- Digitalisation and artificial intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting11/18/2026
- Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/18/2026